Pulmonary Lymphangioleiomyomatosis
2 clinical trials · Condition
◉ Watch Pulmonary Lymphangioleiomyomatosis
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis (NCT02737202) | Baylor College of Medicine | 2016-04-01 |
| The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1) (NCT02116712) | Tony Eissa | 2014-08-01 |
Track Pulmonary Lymphangioleiomyomatosis automatically
Every clearance here is in the API, with alerts when new ones post.